| Literature DB >> 31553469 |
Katherine A Kaplan1, Meital Mashash1, Rayma Williams1, Holly Batchelder2, Lolly Starr-Glass2, Jamie M Zeitzer1.
Abstract
Importance: Owing to biological, behavioral, and societal factors, sleep duration in teenagers is often severely truncated, leading to pervasive sleep deprivation. Objective: To determine whether a novel intervention, using both light exposure during sleep and cognitive behavioral therapy (CBT), would increase total sleep time in teenagers by enabling them to go to sleep earlier than usual. Design, Setting, and Participants: This double-blind, placebo-controlled, randomized clinical trial, conducted between November 1, 2013, and May 31, 2016, among 102 adolescents enrolled full-time in grades 9 to 12, who expressed difficulty going to bed earlier and waking up early enough, was composed of 2 phases. In phase 1, participants were assigned to receive either 3 weeks of light or sham therapy and were asked to try to go to sleep earlier. In phase 2, participants received 4 brief CBT sessions in addition to a modified light or sham therapy. All analyses were performed on an intent-to-treat basis. Interventions: Light therapy consisted of receiving a 3-millisecond light flash every 20 seconds during the final 3 hours of sleep (phase 1) or final 2 hours of sleep (phase 2). Sham therapy used an identical device, but delivered 1 minute of light pulses (appearing in 20-second intervals, for a total of 3 pulses) per hour during the final 3 hours of sleep (phase 1) or 2 hours of sleep (phase 2). Light therapy occurred every night during the 4-week intervention. Cognitive behavioral therapy consisted of four 50-minute in-person sessions once per week. Main Outcomes and Measures: Primary outcome measures included diary-based sleep times, momentary ratings of evening sleepiness, and subjective measures of sleepiness and sleep quality.Entities:
Mesh:
Year: 2019 PMID: 31553469 PMCID: PMC6763980 DOI: 10.1001/jamanetworkopen.2019.11944
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. CONSORT Diagrams of Participant Flow in Phase 1 and Phase 2
CBT indicates cognitive behavioral therapy.
Figure 2. Protocol Diagram
Timing of the different questionnaires (Adolescent Sleep-Wake Scale [ASWS], Cleveland Adolescent Sleepiness Questionnaire [CASQ], Child and Adolescent Sleep Checklist for parents [CASC-P], Credibility/Expectancy Questionnaire [CEQ], and Morningness-Eveningness Scale for Children [MESC]) given during the baseline and end assessments, as well as the ASWS and CASQ given during segments 1 through 4, which were given either over the telephone (phase 1) or in person (phase 2).
Demographic and Clinical Information for Study Samples at Baseline
| Characteristic | Phase 1 | Phase 2 | ||||
|---|---|---|---|---|---|---|
| Light (n = 36) | Sham (n = 36) | Light Plus CBT (n = 15) | Sham Plus CBT (n = 15) | |||
| Age, mean (SD), y | 15.7 (1.6) | 15.4 (1.1) | .29 | 15.6 (1.2) | 15.7 (1.4) | .89 |
| Sex, Female, No. (%) | 21 (58.3) | 18 (50.0) | .64 | 7 (46.7) | 8 (53.3) | >.99 |
| Race, No. (%) | ||||||
| Asian | 7 (19.4) | 2 (5.6) | .21 | 6 (40.0) | 5 (33.3) | .53 |
| Black | 0 | 1 (2.8) | 0 | 0 | ||
| White | 20 (55.6) | 25 (69.4) | 4 (26.7) | 7 (46.7) | ||
| >1 Race | 3 (8.3) | 5 (13.9) | 5 (33.3) | 2 (13.3) | ||
| Unknown or declined | 6 (16.7) | 3 (8.3) | 0 | 1 (6.7) | ||
| Ethnicity, Hispanic, No. (%) | 8 (22.2) | 1 (2.8) | .01 | 1 (6.7) | 0 | >.99 |
| MESC score, mean (SD) | 22.81 (4.04) | 21.64 (3.59) | .20 | 21.93 (3.20) | 21.60 (5.70) | .84 |
Abbreviations: CBT, cognitive behavioral therapy; MESC, Morningness-Eveningness Scale for Children.
Phase 1 and Phase 2 Outcomes by Randomization Condition at Baseline (Week 1) and End-Treatment (Week 5)
| Outcome | Phase 1 | Phase 2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Cohen | Mean (SD) | Cohen | |||||||
| Light (n = 36) | Sham (n = 36) | Time | Time × Treatment | Light Plus CBT (n = 15) | Sham Plus CBT (n = 14) | Time | Time × Treatment | |||
| Sleep diary | ||||||||||
| Sleep onset latency, min | ||||||||||
| Baseline | 35.4 (45.2) | 19.4 (19.6) | −0.09 | −0.14 | 19.9 (18.7) | 17.1 (8.12) | −0.48 | −0.19 | ||
| End of treatment | 26.4 (49.6) | 16.3 (14.7) | 11.3 (6.8) | 10.3 (5.6) | ||||||
| Sleep onset time, h:min | ||||||||||
| Baseline | 24:16 (1:05) | 24:11 (0:59) | −0.28 | −0.22 | 24:21 (0:47) | 23:52 (0:35) | −0.51 | −0.61 | ||
| End of treatment | 24:14 (1:01) | 23:49 (1:01) | 23:31 (0:47) | 23:30 (0:55) | ||||||
| Total sleep time, min | ||||||||||
| Baseline | 445.0 (60.5) | 452.0 (48.0) | 0.29 | 0.02 | 438.9 (30.0) | 462.8 (43.3) | 0.37 | 0.78 | ||
| End of treatment | 460.0 (67.3) | 465.2 (53.8) | 482.1 (37.1) | 474.8 (35.4) | ||||||
| Time in bed, min | ||||||||||
| Baseline | 501.5 (61.9) | 490.3 (54.0) | 0.26 | −0.20 | 481.2 (41.8) | 497.4 (44.7) | 0.13 | 0.50 | ||
| End of treatment | 501.8 (57.3) | 502.7 (59.4) | 506.5 (36.7) | 501.9 (35.6) | ||||||
| Sleep efficiency, % | ||||||||||
| Baseline | 89 (8.5) | 92 (5.0) | 0.07 | 0.25 | 91 (4.9) | 93 (3.0) | 0.51 | 0.39 | ||
| End of treatment | 92 (8.9) | 93 (4.5) | 95 (2.5) | 95 (2.7) | ||||||
| Sleep initiation, h:min | ||||||||||
| Baseline | 23:41 (1:08) | 23:52 (1:02) | −0.27 | 0.35 | 00:01 (0:55) | 23:35 (0:37) | −0.32 | −0.49 | ||
| End of treatment | 23:47 (1:05) | 23:33 (1:01) | 23:19 (0:48) | 23:20 (0:54) | ||||||
| Out of bed, h:min | ||||||||||
| Baseline | 8:04 (0:41) | 8:02 (0:48) | −0.03 | 0.16 | 8:02 (0:34) | 7:51 (0:35) | −0.26 | −0.09 | ||
| End of treatment | 8:09 (0:47) | 7:58 (0:46) | 7:46 (0:38) | 7:42 (0:52) | ||||||
| Sleep quality score | ||||||||||
| Baseline | 3.3 (0.5) | 3.4 (0.5) | 0.26 | −0.10 | 3.4 (0.6) | 3.6 (0.7) | 0.42 | 0.30 | ||
| End of treatment | 3.4 (0.6) | 3.5 (0.5) | 3.9 (0.6) | 3.8 (0.5) | ||||||
| Ecological momentary assessment | ||||||||||
| Evening sleepiness rating | ||||||||||
| Baseline | 3.6 (0.9) | 3.1 (1.1) | 0.36 | 0.03 | 3.4 (1.1) | 3.6 (0.9) | −0.32 | 0.74 | ||
| End of treatment | 4.0 (1.2) | 3.4 (1.3) | 3.9 (1.1) | 3.1 (1.0) | ||||||
| Questionnaire scores | ||||||||||
| CASQ | ||||||||||
| Baseline | 43.5 (8.2) | 41.9 (10.0) | −0.82 | −0.07 | 37.2 (8.7) | 36.6 (8.1) | −0.71 | −0.28 | ||
| End of treatment | 35.3 (7.8) | 34.4 (8.1) | 29.6 (7.5) | 29.9 (9.2) | ||||||
| ASWS | ||||||||||
| Baseline | 17.6 (3.0) | 17.9 (2.8) | 1.33 | 0.03 | 19.6 (2.4) | 18.6 (3.0) | 1.66 | −0.23 | ||
| End of treatment | 21.5 (2.6) | 21.8 (3.8) | 23.3 (2.7) | 23.1 (4.0) | ||||||
| CASC-P | ||||||||||
| Baseline | 17.2 (6.0) | 16.0 (5.0) | −0.21 | 0 | 18.3 (7.2) | 17.9 (8.6) | −0.29 | −0.18 | ||
| End of treatment | 16.2 (5.4) | 15.0 (5.2) | 14.3 (9.5) | 14.8 (8.0) | ||||||
Abbreviations: ASWS, Adolescent Sleep-Wake Scale; CASC-P, Child and Adolescent Sleep Checklist (parent completed); CASQ, Cleveland Adolescent Sleepiness Questionnaire; CBT, cognitive behavioral therapy.
The effect size (Cohen d) is shown for the effect of time (ie, between baseline and end of treatment in the sham group) and the interaction between time and treatment (ie, the differential effect of the treatment over time).
P < .001.
P < .05.
P < .01.
Scores range from 1 to 5, with a higher score indicating better sleep quality.
Scores range from 1 to 7, with a higher score indicating sleepiness.
Figure 3. Change in Total Sleep Time (TST)
Change in TST from ad libitum baseline through the 4 weeks of treatment in the light plus cognitive behavioral therapy (CBT) and sham plus CBT groups. By the end of treatment, those in the group receiving light plus CBT gained more than 40 minutes of extra sleep per night. Data were averaged within individuals by the week and then across individuals and are presented as mean (SD). Vertical lines indicate SD.